Skip to main content

KILL Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™

Aditxt, Inc. requests that their press release NewsItemId: 20250417385764 “Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™” be killed.

The release was issued in error by Aditxt, Inc..

A replacement release will not be issued at this time.

Contacts

Aditxt, Inc.

Corporate Communications

Jeff Ramson, PCG Advisory, Inc.

T: 646-863-6893

contactus@aditxt.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.51
-5.60 (-2.67%)
AAPL  266.76
+2.19 (0.83%)
AMD  194.69
-5.47 (-2.73%)
BAC  51.19
-1.88 (-3.53%)
GOOG  310.58
-4.32 (-1.37%)
META  636.71
-18.95 (-2.89%)
MSFT  383.72
-13.51 (-3.40%)
NVDA  190.31
+0.49 (0.26%)
ORCL  139.89
-8.19 (-5.53%)
TSLA  394.86
-16.96 (-4.12%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.